Abbott Goes After Mylan Over Simcor ANDA
Abbott Laboratories has filed a patent infringement suit in an effort to stop Mylan Inc. from making a generic version of Simcor, a cholesterol treatment that includes Niaspan, another Abbott drug...To view the full article, register now.
Already a subscriber? Click here to view full article